Tydeman, F, Pfeffer, P E, Vivaldi, G, Holt, H, Talaei, M, Jolliffe, D, Davies, G, Lyons, R A, Griffiths, C, Kee, F, Sheikh, A, Shaheen, S O & Martineau, A R 2022, ' Rebound in asthma exacerbations following relaxation of COVID-19 restrictions : a longitudinal population-based study (COVIDENCE UK) ', Thorax . https://doi.org/10.1136/thorax-2022-219591 Tydeman, F, Pfeffer, P E, Vivaldi, G, Holt, H, Talaei, M, Jolliffe, D, Davies, G, Lyons, R A, Griffiths, C, Kee, F, Sheikh, A, Shaheen, S O & Martineau, A R 2022, ' Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK) ', Thorax . https://doi.org/10.1136/thorax-2022-219591
Vivaldi, G, Jolliffe, D A, Holt, H, Tydeman, F, Talaei, M, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Shaheen, S O & Martineau, A R 2022, ' Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273 : A population-based cohort study (COVIDENCE UK) ', The Lancet Regional Health Europe, vol. 22, 100501, pp. 100501 . https://doi.org/10.1016/j.lanepe.2022.100501 Vivaldi, G, Jolliffe, D A, Holt, H, Tydeman, F, Talaei, M, Davies, G A, Lyons, R A, Griffiths, C J, Kee, F, Sheikh, A, Shaheen, S O & Martineau, A R 2022, ' Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK) ', The Lancet regional health. Europe, vol. 22, 100501 . https://doi.org/10.1016/j.lanepe.2022.100501